H Yki-Jarvinen - New England Journal of Medicine, 2004 - content.nejm.org Insulin resistance both precedes and predicts type 2 diabetes mellitus. 1 Although exercise and
weight loss ameliorate insulin resistance and may in some cases prevent or delay onset of the
disease, 2 therapy that combats insulin resistance in those who fail to change their ... Cited by 847 - Related articles - BL Direct - All 6 versions
- ►hopkinsmedicine.org [PDF] SE Kahn, SM Haffner, MA Heise, WH Herman, … - New England Journal …, 2006 - content.nejm.org From the Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle
(SEK); University of Texas Health Science Center at San An tonio, San Antonio (SMH); GlaxoSmith
Kline, King of Prussia, PA (MAH, BGK, MCO), and Harlow, Essex, United King dom (NPJ); ... Cited by 781 - Related articles - BL Direct - All 30 versions
E Chiquette, G Ramirez, R DeFronzo - Archives of internal …, 2004 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ... Cited by 199 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org AC Calkin, JM Forbes, CM Smith, M Lassila, … - … , and vascular biology, 2005 - Am Heart Assoc Methods and Results— Control and diabetic apolipoprotein E–deficient mice received rosiglitazone
or placebo. Diabetic mice demonstrated a 3-fold increase in plaque area, which was attenuated
by rosiglitazone. There was no significant difference in glucose, insulin, or cholesterol ... Cited by 79 - Related articles - All 9 versions
PA Sarafidis, AN Lasaridis, PM Nilsson, EM … - Journal of …, 2004 - journals.lww.com Page 1. Ambulatory blood pressure reduction after rosiglitazone treatment in patients
with type 2 diabetes and hypertension correlates with insulin sensitivity increase
Panteleimon A. Sarafidisa, Anastasios N. Lasaridisa, Peter M. Nilssonb, ... Cited by 67 - Related articles - BL Direct - All 5 versions
- ►shouxi.net DM Nathan - New England Journal of Medicine, 2006 - content.nejm.org The twin epidemics of obesity and type 2 diabe- tes mellitus have spawned a public health
crisis. In the United States, an estimated 1.5 million new cases of diabetes occur every year,
1 and the pro- jected microvascular and cardiovascular complica- tions 2 — already the ... Cited by 65 - Related articles - BL Direct - All 10 versions
VA Fonseca - The American journal of cardiology, 2003 - Elsevier Patients with diabetes have a greatly increased relative risk of developing cardiovascular disease
when compared with patients without diabetes. Much of this risk is related to insulin resistance
and is associated with both traditional and nontraditional cardiovascular risk factors. ... Cited by 55 - Related articles - All 11 versions
Z Kerenyi, H Samer, R James, Y Yan, M Stewart - Diabetes research and clinical …, 2004 - Elsevier Aim: To compare the efficacy of combination therapy using rosiglitazone (8 mg per day) and
glibenclamide (7.5 mg per day) with upward titration of glibenclamide as monotherapy (maximum
dose=15 mg per day) in reducing HbA 1c levels over 26 weeks in patients with type 2 ... Cited by 50 - Related articles - All 8 versions
SE Kahn, B Zinman, SM Haffner, MC O'Neill, BG Kravitz … - Diabetes, 2006 - Am Diabetes Assoc The inflammatory factor C-reactive protein (CRP) and the fibrinolytic variables fibrinogen and
plasminogen activator-1 (PAI-1) are associated with long-term cardiovascular morbidity. To determine
the contribution of body adiposity (BMI), insulin sensitivity (homeostasis model ... Cited by 55 - Related articles - BL Direct - All 17 versions
